Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute 
United Airlines Tokyo-Bound Flight Returns to Dulles After Engine Failure 
Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push 
Strategy Retains Nasdaq 100 Spot Amid Growing Scrutiny of Bitcoin Treasury Model 
EU Signals Major Shift on 2035 Combustion Engine Ban Amid Auto Industry Pressure 
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 
Trump Sues BBC for Defamation Over Edited Capitol Riot Speech Clip 
Shell M&A Chief Exits After BP Takeover Proposal Rejected 
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit 
Nomura Expands Alternative Assets Strategy With Focus on Private Debt Acquisitions 
SpaceX Begins IPO Preparations as Wall Street Banks Line Up for Advisory Roles 
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation 
noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking. 
Fortescue Expands Copper Portfolio With Full Takeover of Alta Copper 
Woolworths Faces Fresh Class Action Over Alleged Underpayments, Shares Slide 
CMOC to Acquire Equinox Gold’s Brazilian Mines in $1 Billion Deal to Expand Precious Metals Portfolio 
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates 
HUDSON, N.H., Sept. 08, 2016 -- S-BIO1 has launched today EZGlycoTM mAb-N Kit with 2-AB, a breakthrough new product that enables scientists to analyze N-glycans in IgG and Fc-fusion proteins from culture supernatant samples in a rapid, simplified and streamlined single tube operation. The kit is a valuable tool supporting customers in glycoprotein characterization for biotherapeutic development.
Therapeutic monoclonal antibodies (IgG, mAb) are routinely expressed in recombinant expression systems. N-glycosylation is one of the most important post-translational modifications. Monitoring of glycosylation in antibody development and production directly from cell culture media will shorten the time needed to obtain the N-glycan profiling. HPLC-ready glycan preparation can be performed in less than 2 hours, allowing scientists to purify IgG from cell culture supernatant, release and label N-glycans in one complete kit. “The EZGlyco mAb-N Kit with 2-AB streamlined and rapid N-glycan preparation from IgG cell culture supernatant circumvents use of other kits for IgG purification and provides unmatched speed, ease of use, and compatibility with HPLC,” states Dr. Anju M. Dang, Director, S-BIO.
The new EZGlycoTM mAb-N Kit with 2-AB is currently available in the U.S. through S-BIO, Vaupell Holdings Inc. (http://s-bio.com/products/ezglyco-mab-n/), a Sumitomo Bakelite Co., Ltd. group company.
About S-BIO
S-BIO is a division of Sumitomo Bakelite Co., Ltd. (a pioneer in plastics with products used for wide-ranging applications such as IT components and material, high performance plastics and quality-of-life product). S-BIO’s main product and services fall into two categories: glycan analysis related services and products, and high performance labware for cell culture applications.
Glossary
1S-BIO, U.S.
S-BIO is a division of Sumitomo Bakelite that specializes in providing glycan analysis products and tools to advance glycomics research, and 3D cell culture plates for cancer and stem cell research.
S-BIO’s analytical services are based on a proprietary GlycanMap® platform, which provides rapid and efficient analysis of both N-linked and O-linked glycans in glycoproteins. GlycanMap® technology combines BlotGlyco® bead-based glycan purification in a fully automated sample processing system with high-throughput MALDI-TOF mass spectrometry to generate rapid, reproducible glycan profiles for bioprocess and biomarker discovery. With an established laboratory at Hudson, NH, S-BIO supports the advancement of customer needs in the fields of drug discovery, regenerative medicine, stem cell and cancer research, and glycobiology.
Registered trademarks are trademarks of their respective companies.
Anju M. Dang, Ph.D. S-BIO, Sumitomo Bakelite Co., Ltd. Tel: (603) 425-9697 E-mail: [email protected]
